Seven Eight Capital’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,872
Closed -$3.3M 374
2024
Q3
$3.3M Buy
9,872
+4,966
+101% +$1.89M 0.3% 78
2024
Q2
$2.02M Sell
4,906
-2,009
-29% -$796K 0.21% 132
2024
Q1
$2.79M Buy
+6,915
New +$2.43M 0.29% 97
2019
Q4
Sell
-8,443
Closed -$710K 713
2019
Q3
$710K Buy
+8,443
New +$638K 0.04% 474

Other funds holding MEDP

Seven Eight Capital's MEDP Position: Q4 2024 in Review

Seven Eight Capital sold out of Medpace (MEDP) in Q4 2024, closing a stake of 9,872 shares — an estimated $3.3M sold.

Seven Eight Capital first reported a position in MEDP in Q3 2019 and held it in 4 quarters. The position peaked at $3.3M in Q3 2024. 592 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

  • Seven Eight Capital reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
  • Seven Eight Capital sold 9,872 Medpace shares in Q4 2024, an estimated $3.3M.
  • Seven Eight Capital first reported a position in Medpace in Q3 2019 and held it in 4 quarters.
  • Seven Eight Capital's Medpace position peaked at $3.3M in Q3 2024.
  • 592 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on Seven Eight Capital's 13F filing for Q4 2024.